Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

DAXX/ATRX and MEN1 genes are strong prognostic markers in pancreatic neuroendocrine tumors

18 May 2017

Abstract excerpt

// Joo Kyung Park 1, * , Woo Hyun Paik 2, * , Kyoungbun Lee 3, * , Ji Kon Ryu 2 , Sang Hyub Lee 2 and Yong-Tae Kim 2 1 Division of Gastroenterology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea 2 Department of Internal Medicine and Liver Research Institutute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenal and Paraganglionic Tumors
Share to Neuroendocrine Tumor Research Advances
Share to Pancreatic and Hepatic Oncology Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28591701
DOI: 10.18632/oncotarget.17964

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

DAXX/ATRX and MEN1 genes are strong prognostic markers in pancreatic neuroendocrine tumorsPMID 28591701Read ↗

Clinicopathological and molecular determinants of pancreatic neuroendocrine tumors: toward precision risk stratification.Semantic proximity Read ↗

KRAS and DAXX/ATRX gene mutations are correlated with the clinicopathological features, advanced diseases, and poor prognosis in Chinese patients with pancreatic neuroendocrine tumors.Semantic proximity Read ↗

DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors.Semantic proximity Read ↗

Immunohistochemistry based molecular subtyping of pancreatic neuroendocrine tumor correlates with clinicopathological outcome: A single institute retrospective studySemantic proximity Read ↗

ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroupSemantic proximity Read ↗

Insights into Epigenetic Changes Related to Genetic Variants and Cells-of-Origin of Pancreatic Neuroendocrine Tumors: An Algorithm for Practical WorkupSemantic proximity Read ↗

<i>ATRX, DAXX or MEN1</i> mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroupSemantic proximity Read ↗

Pancreatic Neuroendocrine Neoplasms: Basic Biology, Current Treatment Strategies and Prospects for the FutureSemantic proximity Read ↗

Loss of ATRX and DAXX in pancreatic neuroendocrine tumors: Association with recurrence risk, cellular phenotype, and heterogeneity.Semantic proximity Read ↗

Genetic and epigenetic alterations in pancreatic neuroendocrine tumorsSemantic proximity Read ↗

Molecular biology of pancreatic neuroendocrine tumors: From mechanism to translationSemantic proximity Read ↗

Updates on the Role of Molecular Alterations and NOTCH Signaling in the Development of Neuroendocrine NeoplasmsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.